MDXG
$6.33
Revenue | $86.83Mn |
Net Profits | $62.69Mn |
Net Profit Margins | 72.19% |
PE Ratio | 14.77 |
Mimedx Group, Inc.’s revenue jumped 16.75% since last year same period to $86.83Mn in the Q4 2023. On a quarterly growth basis, Mimedx Group, Inc. has generated 6.27% jump in its revenue since last 3-months.
Mimedx Group, Inc.’s net profit jumped 15205.54% since last year same period to $62.69Mn in the Q4 2023. On a quarterly growth basis, Mimedx Group, Inc. has generated 827.2% jump in its net profits since last 3-months.
Mimedx Group, Inc.’s net profit margin jumped 13038.49% since last year same period to 72.19% in the Q4 2023. On a quarterly growth basis, Mimedx Group, Inc. has generated 772.53% jump in its net profit margins since last 3-months.
Mimedx Group, Inc.’s price-to-earnings ratio after this Q4 2023 earnings stands at 14.77.
EPS Estimate Current Quarter | 0.04 |
EPS Estimate Current Year | 0.04 |
Mimedx Group, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.04 - a -42.86% fall from last quarter’s estimates.
Mimedx Group, Inc.’s earning per share (EPS) estimates for the current year stand at 0.04.
Earning Per Share (EPS) | 0.32 |
Return on Assets (ROA) | 0.11 |
Return on Equity (ROE) | 0.62 |
Mimedx Group, Inc.’s earning per share (EPS) jumped 1700% since last year same period to 0.32 in the Q4 2023. This indicates that the Mimedx Group, Inc. has generated 1700% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Mimedx Group, Inc.’s return on assets (ROA) stands at 0.11.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Mimedx Group, Inc.’s return on equity (ROE) stands at 0.62.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-01 | -0.02 | -0 | 77% |
2023-05-02 | -0.09 | -0.06 | 33.33% |
2023-10-30 | 0.05 | 0.06 | 20% |
2024-02-28 | 0.07 | 0.32 | 357.14% |